Food & Function,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Diabetic
Kidney
Disease
(DKD)
is
a
common
and
serious
complication
of
diabetes,
particularly
Type
2
Diabetes
Mellitus
(T2DM),
which
significantly
contributes
to
patient
morbidity
mortality.
The
limitations
traditional
treatments
like
ACE
inhibitors
ARBs
in
managing
DKD
progression
highlight
the
need
for
innovative
therapeutic
strategies.
This
review
examines
impact
various
dietary
patterns,
such
as
Mediterranean
diet,
ketogenic
intermittent
fasting,
DASH
vegetarian
on
management
DKD.
Evidence
suggests
these
diets
can
halt
DKD,
although
further
research
needed
confirm
their
long-term
effectiveness
safety.
Personalized
approaches
tailored
individual
needs
may
enhance
outcomes
patients.
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(15), P. 3368 - 3368
Published: July 28, 2023
The
most
common
and
increasing
causes
of
death
worldwide
are
cardiovascular
diseases
(CVD).
Taking
into
account
the
fact
that
diet
is
a
key
factor,
it
worth
exploring
this
aspect
CVD
prevention
therapy.
aim
article
to
assess
potential
ketogenic
in
treatment
CVD.
comprehensive,
meticulous
analysis
literature
area,
taking
recent
studies
currently
available.
has
been
shown
have
multifaceted
effect
on
Among
other
aspects,
beneficial
blood
lipid
profile,
even
compared
diets.
It
shows
strong
anti-inflammatory
cardioprotective
potential,
which
due,
among
factors,
properties
state
ketosis,
elimination
simple
sugars,
restriction
total
carbohydrates
supply
omega-3
fatty
acids.
In
addition,
ketone
bodies
provide
"rescue
fuel"
for
diseased
heart
by
affecting
its
metabolism.
They
also
function
vascular
endothelium,
including
improving
inhibiting
premature
ageing.
pressure
risk
factors
through,
weight
loss.
evidence
cited
often
superior
standard
diets,
making
likely
advantages
over
dietary
models
diseases.
There
legitimate
need
further
research
area.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(17), P. 13381 - 13381
Published: Aug. 29, 2023
Diabetes
mellitus
is
a
chronic
multifaceted
disease
with
multiple
potential
complications,
the
treatment
of
which
can
only
delay
and
prolong
terminal
stage
disease,
i.e.,
type
2
diabetes
(T2DM).
The
World
Health
Organization
predicts
that
will
be
seventh
leading
cause
death
by
2030.
Although
many
antidiabetic
medicines
have
been
successfully
developed
in
recent
years,
such
as
GLP-1
receptor
agonists
SGLT-2
inhibitors,
single-target
drugs
are
gradually
failing
to
meet
therapeutic
requirements
owing
individual
variability,
diversity
pathogenesis,
organismal
resistance.
Therefore,
there
remains
need
investigate
pathogenesis
T2DM
more
depth,
identify
targets,
provide
improved
glycemic
control
solutions.
This
review
presents
an
overview
mechanisms
action
development
latest
agents
targeting
years.
It
also
discusses
emerging
target-based
therapies
new
targets
emerged
within
last
three
aim
our
theoretical
basis
for
further
advancement
targeted
T2DM.
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(14), P. 3120 - 3120
Published: July 12, 2023
The
ketogenic
diet
(KD)
is,
nowadays,
considered
an
interesting
nutritional
approach
for
weight
loss
and
improvement
in
insulin
resistance.
Nevertheless,
most
of
the
studies
available
literature
do
not
allow
a
clear
distinction
between
its
effects
on
sensitivity
per
se,
induced
by
KDs
sensitivity.
In
this
review,
we
discuss
scientific
evidence
direct
mediated
glycemic
status
humans,
describing
KD's
biochemical
background
underlying
mechanisms.
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(3), P. 500 - 500
Published: Jan. 18, 2023
The
exponentially
growing
frequency
of
diagnosing
diabetes
mellitus
means
that
a
verification
the
previous
dietetic
approach
to
treating
disease
seems
justified.
simultaneous
growth
interest
in
ketogenic
diet
and
development
knowledge
this
field
have
contributed
increasingly
frequent
application
treatment.
This
paper
also
deals
with
issue;
its
aim
includes
an
extensive
analysis
influence
on
prophylaxis
treatment
diabetes.
has
been
prepared
based
wide,
meticulous
available
literature
subject.
Among
other
findings,
favorable
effect
nutrition
model
demonstrated
values
glycated
hemoglobin,
glucose,
insulin,
or
metabolic
parameters
patients.
pharmacotherapy
type
1
2
presented
compared
standard
nutritional
management
plan
recommended
for
disease.
Further
research
is
needed
field,
especially
studies
long
follow-up
period.
discussed
articles
report
interesting
therapeutic
advantages
comparison
diets.
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(14), P. 3156 - 3156
Published: July 15, 2023
Background:
Dietary
patterns
play
a
critical
role
in
diabetes
management,
while
the
best
dietary
pattern
for
Type
2
(T2DM)
patients
is
still
unclear.
The
aim
of
this
network
meta-analysis
was
to
compare
impacts
various
approaches
on
glycemic
control
T2DM
patients.
Methods:
Relevant
studies
were
retrieved
from
PubMed,
Embase,
Web
Knowledge,
Cochrane
Central
Register
Controlled
Trials
(CENTRAL),
and
other
additional
records
(1949
31
July
2022).
Eligible
RCTs
those
comparing
different
against
each
or
diet
individuals
with
at
least
6
months.
We
assessed
risk
bias
included
tool
confidence
estimates
Grading
Recommendations
Assessment,
Development,
Evaluation
approach
meta-analyses.
In
order
determine
pooled
effect
relative
other,
we
performed
(NMA)
interventions
both
HbA1c
fasting
glucose,
which
enabled
us
estimate
intervention
effects
by
combing
direct
indirect
trial
evidence.
Results:
Forty-two
comprising
4809
NMA,
10
(low-carbohydrate,
moderate-carbohydrate,
ketogenic,
low-fat,
high-protein,
Mediterranean,
Vegetarian/Vegan,
low
index,
recommended,
diets).
total,
83.3%
lower
had
some
concerns.
Findings
NMA
revealed
that
low-carbohydrate,
low-fat
diets
significantly
effective
reducing
(viz.,
−0.73
(−1.19,
−0.28),
−0.69
(−1.32,
−0.06),
−1.82
(−2.93,
−0.71)),
glucose
−1.30
(−1.92,
−0.67),
−1.26
(−2.26,
−0.27),
−0.95
(−1.51,
−0.38),
−0.89
(−1.60,
−0.18)
−0.75
(−1.24,
−0.27))
compared
diet.
clustered
ranking
plot
combined
outcomes
indicated
index
promising
controlling
glucose.
univariate
meta-regressions
showed
mean
reductions
only
related
weight
change
subjects.
Conclusions:
For
patients,
ketogenic
diet,
Mediterranean
moderate-carbohydrate
options.
Although
study
found
superior,
further
high-quality
long-term
are
needed
strengthen
its
credibility.
Current Problems in Cardiology,
Journal Year:
2024,
Volume and Issue:
49(3), P. 102402 - 102402
Published: Jan. 21, 2024
The
ketogenic
diet
is
based
on
extreme
carbohydrate
intake
reduction
and
replacing
the
remaining
with
fat
has
become
a
popular
dietary
pattern
used
for
weight
loss.
relationship
between
cardiovascular
risk
controversial
topic.
This
publication
aimed
to
present
evidence
factors
mortality.
does
not
fulfill
criteria
of
healthy
diet.
It
presents
potential
rapid
short-term
body
mass,
triglycerides
level,
Hb1Ac,
blood
pressure.
Its
efficacy
loss
above-mentioned
metabolic
changes
significant
in
long-term
observations.
In
terms
mortality,
low-carb
more
beneficial
than
very
low-carbohydrate
(including
diet).
There
still
scarce
comparing
Mediterranean
Other
safety
concerns
patients
such
as
adverse
events
related
ketosis,
fat-free
mass
loss,
or
pharmacological
interactions
should
be
also
taken
into
consideration
future
research.
Frontiers in Nutrition,
Journal Year:
2024,
Volume and Issue:
11
Published: Feb. 29, 2024
There
is
a
substantial
body
of
clinical
evidence
supporting
the
beneficial
effects
lower-carbohydrate
dietary
patterns
on
multiple
established
risk
factors
associated
with
insulin
resistance
and
cardiovascular
diseases
in
adult
populations.
Nutrition
health
researchers,
practitioners,
stakeholders
gathered
for,
“The
Scientific
Forum
Nutrition,
Wellness,
Lower-Carbohydrate
Diets:
An
Evidence-
Equity-Based
Approach
to
Dietary
Guidance”
discuss
base
around
diets,
outcomes,
guidance.
Consensus
statements
were
agreed
upon
identify
current
areas
scientific
agreement
spotlight
gaps
research,
education,
practice
help
define
prioritize
future
pathways.
Given
considering
that
most
American
adults
are
living
at
least
one
nutrition-related
chronic
disease,
there
was
consensus
including
pattern
as
part
Guidelines
for
Americans
could
promote
equity
among
general
population.
Summary
Background
The
current
obesity
pandemic
has
given
rise
to
associated
comorbidities
and
complications,
including
type
2
diabetes
metabolic
dysfunction‐associated
steatotic
liver
disease
(MASLD).
During
the
last
decade,
certain
glucagon‐like
peptide
1
receptor
agonists
(GLP‐1RA),
originally
developed
as
antihyperglycemic
drugs,
also
demonstrated
efficacy
for
weight
loss.
Aims
To
review
shared
pathophysiologic
features
of
common
diseases
compare
therapeutic
strategies
reduce
body
related
complications.
Methods
We
performed
an
extensive
literature
research
describe
effects
lifestyle
modification,
first‐generation
anti‐obesity
GLP‐1RA
on
loss
in
humans
with
obesity,
MASLD.
Results
Until
recently,
treatment
been
limited
which
offer
moderate
degree
sustainability
few
approved
drugs
are
either
short
term
use
or
forms
obesity.
Some
significantly
decrease
caloric
intake
weight.
Liraglutide
semaglutide
have
therefore
treating
people
They
lead
a
reduction
hepatic
fat
content
inflammation
biopsy‐confirmed
Possible
limitations
comprise
adverse
effects,
adherence
persistence.
Conclusion
Certain
superior
modification
inducing
markedly
changed
portfolio
additional
beneficial
disease.
Nutrients,
Journal Year:
2025,
Volume and Issue:
17(6), P. 965 - 965
Published: March 10, 2025
With
the
prevalence
of
obesity
and
overweight
increasing
at
an
alarming
rate,
more
researchers
are
focused
on
identifying
effective
weight
loss
strategies.
The
ketogenic
diet
(KD),
used
as
a
treatment
in
epilepsy
management
for
over
100
years,
is
additionally
gaining
popularity
method.
Although
its
efficacy
well
documented,
areas
where
it
may
be
beneficial
to
other
dietary
approaches
need
carefully
examined.
objective
this
paper
identify
potential
benefits
KD
alternative
strategies
based
comprehensive
literature
review.
It
has
been
shown
that
bioenergetically
efficient
than
strategies,
inter
alia
owing
effect
curtailing
hunger,
improving
satiety
decreasing
appetite
(influence
hunger
hormones
sensation
hunger),
inducing
faster
initial
(associated
with
lower
glycogen
levels
reduced
water
retention),
controlling
glycaemia
insulinemia
(directly
attributable
low-carbohydrate
nature
indirectly
described).
These
effects
accompanied
by
improved
insulin
sensitivity,
inflammation
(through
ketone
bodies
avoidance
pro-inflammatory
sugars),
pharmacological
control
(the
diet’s
mechanisms
similar
those
medication
but
without
side
effects),
positive
impacts
psychological
factors
food
addiction.
Based
authors’
review
latest
research,
reasonable
conclude
that,
due
these
many
additional
health
benefits,
advantageous
diet-based
This
important
hypothesis
deserves
further
exploration,
which
could
achieved
including
outcome
measures
future
clinical
trials,
especially
when
comparing
different
diets
equal
caloric
value.